688639.SH
华恒生物
SSE · Healthcare · Biotechnology · CN
CNY 16.08
−3.65%Margins
Gross margin
20.5%
EBITDA margin
11.9%
EBIT margin
3.8%
Net margin
4.2%
FCF margin
-20.7%
4.6%
Return on equity
2.0%
Return on assets
2.4%
Return on invested capital
0.50x
Asset turnover
CNY 101.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026